These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 21321840

  • 1. Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy.
    Svensson MK, Eriksson JW.
    Horm Metab Res; 2011 Mar; 43(3):209-15. PubMed ID: 21321840
    [Abstract] [Full Text] [Related]

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 3. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 4. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A, Earle KA, Rodemann HP, Viberti GC.
    Diabetologia; 1997 Feb; 40(2):244-6. PubMed ID: 9049488
    [Abstract] [Full Text] [Related]

  • 5. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA.
    N Engl J Med; 1991 Jun 06; 324(23):1626-32. PubMed ID: 2030719
    [Abstract] [Full Text] [Related]

  • 6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.
    Am J Kidney Dis; 2001 Aug 06; 38(2):310-6. PubMed ID: 11479157
    [Abstract] [Full Text] [Related]

  • 7. A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy.
    Svensson M, Yu ZW, Eriksson JW.
    Eur J Clin Invest; 2002 Feb 06; 32(2):100-9. PubMed ID: 11895456
    [Abstract] [Full Text] [Related]

  • 8. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.
    Diabetes Care; 2008 Jun 06; 31(6):1170-6. PubMed ID: 18332153
    [Abstract] [Full Text] [Related]

  • 9. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J, Bastos M, Melo M, Carvalheiro M.
    Acta Med Port; 2007 Jun 06; 20(2):145-50. PubMed ID: 17868520
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.
    Am J Kidney Dis; 2007 Feb 06; 49(2):237-44. PubMed ID: 17261426
    [Abstract] [Full Text] [Related]

  • 11. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.
    J Intern Med; 2004 Dec 06; 256(6):510-8. PubMed ID: 15554952
    [Abstract] [Full Text] [Related]

  • 12. Familial factors in diabetic nephropathy: an offspring study.
    Agius E, Attard G, Shakespeare L, Clark P, Vidya MA, Hattersley AT, Fava S.
    Diabet Med; 2006 Mar 06; 23(3):331-4. PubMed ID: 16492220
    [Abstract] [Full Text] [Related]

  • 13. Enhanced G protein activation in IDDM patients with diabetic nephropathy.
    Pietruck F, Spleiter S, Daul A, Philipp T, Derwahl M, Schatz H, Siffert W.
    Diabetologia; 1998 Jan 06; 41(1):94-100. PubMed ID: 9498636
    [Abstract] [Full Text] [Related]

  • 14. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.
    Platelets; 2010 Jan 06; 21(7):525-32. PubMed ID: 20701458
    [Abstract] [Full Text] [Related]

  • 15. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N, Salinas I, Bonal J, Bayés B, Riba J, Torres F, Rios J, Sanmartí A, Romero R.
    Nephrol Dial Transplant; 2006 Aug 06; 21(8):2152-8. PubMed ID: 16702203
    [Abstract] [Full Text] [Related]

  • 16. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH.
    Am J Kidney Dis; 2001 Dec 06; 38(6):1376-80. PubMed ID: 11728978
    [Abstract] [Full Text] [Related]

  • 17. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.
    Metabolism; 2009 Jun 06; 58(6):860-6. PubMed ID: 19375766
    [Abstract] [Full Text] [Related]

  • 18. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J, Lindmark S, Renström F, Eriksson JW.
    Metabolism; 2003 Feb 06; 52(2):239-45. PubMed ID: 12601640
    [Abstract] [Full Text] [Related]

  • 19. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
    González-Clemente JM, Mauricio D, Richart C, Broch M, Caixàs A, Megia A, Giménez-Palop O, Simón I, Martínez-Riquelme A, Giménez-Pérez G, Vendrell J.
    Clin Endocrinol (Oxf); 2005 Nov 06; 63(5):525-9. PubMed ID: 16268804
    [Abstract] [Full Text] [Related]

  • 20. [Type 1 diabetes mellitus and nephropathy. Predicting factors in pediatric age].
    Orejas R-Arango G, del Molino Anta A, Santos Rodríguez F, Crespo Hernández M, García Vicente S, Rey Galan C, Macho Montoya V, Málaga Guerrero S.
    An Esp Pediatr; 1992 Jul 06; 37(1):37-41. PubMed ID: 1416521
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.